Financial reports
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
13 Mar 20
10-Q
2019 Q3
Quarterly report
7 Nov 19
10-Q
2019 Q2
Quarterly report
9 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K/A
2018 FY
Annual report (amended)
30 Apr 19
10-K
2018 FY
Annual report
15 Mar 19
10-Q
2018 Q3
Quarterly report
8 Nov 18
10-Q
2018 Q2
Quarterly report
31 Jul 18
10-Q
2018 Q1
Quarterly report
9 May 18
Current reports
8-K
Lantheus Completes Merger with Progenics
22 Jun 20
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 20
8-K
Progenics Stockholders Approve Merger with Lantheus
16 Jun 20
8-K
Departure of Directors or Certain Officers
11 Jun 20
8-K
Other Events
8 Jun 20
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
28 May 20
8-K
Regulation FD Disclosure
18 May 20
8-K
Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
7 May 20
8-K
Velan Capital Agrees to Support Merger of Lantheus and Progenics
14 Apr 20
8-K
Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger
2 Apr 20
Registration and prospectus
15-12G
Securities registration termination
2 Jul 20
25-NSE
Exchange delisting
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jun 20
POS AM
Prospectus update (post-effective amendment)
22 Jun 20
Proxies
DEFA14A
Additional proxy soliciting materials
14 May 20
DEFM14A
Proxy related to merger
19 Mar 20
DEFA14A
Additional proxy soliciting materials
8 Nov 19
DFAN14A
Additional proxy materials by non-management
8 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DFAN14A
Additional proxy materials by non-management
5 Nov 19
DEFA14A
Additional proxy soliciting materials
5 Nov 19
DFAN14A
Additional proxy materials by non-management
4 Nov 19
DFAN14A
Additional proxy materials by non-management
28 Oct 19
DFAN14A
Additional proxy materials by non-management
24 Oct 19
Other
EFFECT
Notice of effectiveness
8 Jul 20
UPLOAD
Letter from SEC
29 Nov 19
CORRESP
Correspondence with SEC
6 Nov 19
UPLOAD
Letter from SEC
7 Oct 19
CORRESP
Correspondence with SEC
4 Oct 19
UPLOAD
Letter from SEC
2 Oct 19
UPLOAD
Letter from SEC
26 Sep 19
CORRESP
Correspondence with SEC
28 May 19
UPLOAD
Letter from SEC
28 May 19
UPLOAD
Letter from SEC
16 May 19
Ownership
SC 13G/A
FARALLON CAPITAL MANAGEMENT LLC
8 Feb 22
SC 13G/A
FARALLON CAPITAL MANAGEMENT LLC
16 Feb 21
4
Asha Das
23 Jun 20
4
Benedict Osorio
23 Jun 20
4
Bryce Tenbarge
23 Jun 20
4
Vivien Wong
23 Jun 20
4
David W. Mims
23 Jun 20
4
Gerard Ber
23 Jun 20
4
Bradley L Campbell
23 Jun 20
4
Eric J Ende
23 Jun 20